Concordia Healthcare acquires legacy pharmaceutical products and acquires and develops orphan drugs.
Concordia is focused on acquiring Specialty Healthcare and Pharmaceutical Distribution companies.
Concordia Healthcare is listed on the TSX Exchange under (TSX:CXR).
May 14, 2015
– First quarter 2015 revenue increase of 117% compared to the first quarter of ...
May 7, 2015
Photodynamic therapy with PHOTOFRIN® being studied in range of cancers OAKVILLE, ON, May 7, 2015 /CNW/ ...